MDXH:NASDAQMDxHealth SA analysis
Data as of Oct 14, 2026 - not real-time
- Latest price
- $0.63
- Risk: high
- 9/10High risk
Summary
MDxHealth SA trades at $0.6317, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Over a rolling month the price has lost 12.3%. Relative strength is 52.9 — neutral — and the MACD signal is bullish. Recent trading has carved out support near $0.5190 and resistance around $0.7030.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 184.9% above the current quote. Revenue is growing at 2.3% on a -32.7% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 65.8%, a beta of 1.52 and a maximum drawdown of 92.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 184.9% above the current quote. Revenue is growing at 2.3% on a -32.7% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 65.8%, a beta of 1.52 and a maximum drawdown of 92.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Top market events
- Second quarter revenue growth of 16% to $27- 2 millionConference call with Q&A today at 4- 30 PM EST / 22- 30 CET...
- MDxHealth stock has surged in August after the company reported second quarter 2026 revenue growth t
- MDxHealth stock reflects the company’s most recent quarterly results as of September 19, 2026, with
Market outlook
Short term
< 1 yearNeutral
Model confidence2/102 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.72
- MACD momentum is positive
Medium term
1–3 yearsNeutral
Model confidence1/101 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.72
- Analyst targets imply +184.9% versus the current price
Long term
> 3 yearsNeutral
Model confidence1/101 out of 10
Key factors
- Negative profit margin of -32.7%
- Analyst targets imply +184.9% versus the current price
- Negative free cash flow
Key metrics
Financial health
Revenue Growth2.30%
Profit Margin-32.74%
P/E Ratio-1.7
ROA-9.83%
P/B Ratio-1.1
Op. Cash Flow$-5300000
Free Cash Flow$-17405124
Industry P/E31.0
Technical analysis
TrendBearish
RSI52.9
Support$0.52
Resistance$0.70
MA 20$0.60
MA 50$0.64
MA 200$1.72
MACDBullish
VolumeDecreasing
Fear & Greed Index91.3
Valuation
Target Price$1.80
Upside/Downside184.95%
GradeFair
TypeBlend
Risk assessment
Beta1.52
Volatility65.83%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.